SLB SLB N.V. - Fundamental Analysis
NEUTRAL
Sign in to save
Save this symbol to a watchlist or track a position.
SLB Stock | Fundamental Analysis & Investment Insights
NYSE
Energy
Oil & Gas Equipment & Services
Current Price
Live
$46.73
Analyst Target
$48.64
+4.1%
Upside
52W High
$47.73
52W Low
$31.11
At a glance
Key valuation, profitability, growth, and risk metrics.
Updated Jan 17, 2026
Market cap
$69.81B
P/E
18.18
ROE
15.2%
Profit margin
10.3%
Debt/Equity
0.47
Dividend yield
2.45%
AI Analysis
Powered by advanced machine learning algorithms
Confidence Score
72%
Analysis Accuracy
SLB's deterministic health score is concerning with a Piotroski F-Score of 4/9, indicating marginal financial stability. While profitability metrics like ROE (15.18%) and ROA (6.86%) are solid and above sector averages, earnings and revenue growth are negative YoY (-39.80% and -2.50% respectively), and recent earnings surprises have been sharply negative. The stock trades above the Graham Number ($31.5) and intrinsic value estimate ($17.99), suggesting overvaluation, despite a reasonable P/E of 18.18 relative to peers. Analysts maintain a strong_buy consensus, but insider selling and weakening fundamentals temper bullish sentiment.
Key Strengths
Solid return metrics: ROE (15.18%) and ROA (6.86%) exceed sector averages
Moderate leverage with a Debt/Equity ratio of 0.47, below sector average of 0.56
Healthy dividend yield of 2.45% with a sustainable payout ratio of 43.97%
Current Price ($46.73) is below analyst target price of $48.64, implying upside potential
Strong long-term price performance: +104.7% over 5 years
Key Risks
Weak Piotroski F-Score of 4/9 suggests deteriorating financial health
Sharp decline in earnings: YoY EPS growth down 43.8% and Q/Q down 32.4%
Negative revenue growth of -2.50% YoY, underperforming sector average of +2.17%
Recent earnings misses: 1 out of last 4 quarters beat estimates, with average surprise of -14.75%
Bearish insider activity: $5.3M in net insider sales over last 6 months
AI Fair Value Estimate
Based on comprehensive analysis
$31.5
-32.6% below current price
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Overall
55
Moderate
52
40
68
45
70
AI Verdict
Neutral with caution due to weakening fundamentals despite strong profitability and analyst support
Key drivers: Piotroski F-Score of 4 limits health score, Earnings and revenue declines drag future outlook, Valuation above Graham Number but below analyst target, Insider selling contrasts with analyst bullishness, Dividend stability supports income appeal
Confidence
75%
Value
52/100
Ref P/E, PEG, Graham Number
Positives
- P/E of 18.18 is below sector average of 19.81
- Forward P/E of 15.85 suggests earnings recovery expected
Watchpoints
- Stock trades at 48% premium to Graham Number ($31.5)
- Intrinsic value estimate ($17.99) is significantly below current price
Future
40/100
Ref Growth rates
Positives
- Analyst target implies 4.1% upside to $48.64
Watchpoints
- Revenue growth YoY: -2.50%
- Earnings growth YoY: -39.80%
- Q/Q EPS growth: -32.4%
- PEG Ratio unavailable due to negative growth
Past
68/100
Ref Historical trends
Positives
- 5-year price return of +104.7% shows strong long-term appreciation
- Historically consistent earnings beats prior to recent quarters
- Profit margins (10.34%) near sector average
Watchpoints
- Recent quarters show deteriorating earnings performance
- Last 4 quarters averaged -14.75% earnings surprise
Health
45/100
Ref Altman Z-Score, Piotroski F-Score
Positives
- Debt/Equity of 0.47 is conservative
- Current Ratio of 1.39 indicates short-term liquidity
Watchpoints
- Piotroski F-Score of 4/9 indicates weak financial health
- Quick Ratio of 0.90 is below 1.0, suggesting liquidity pressure
Dividend
70/100
Ref Yield, Payout
Positives
- Dividend yield of 2.45% is attractive in current market
- Payout ratio of 43.97% is sustainable
Watchpoints
- Dividend Strength score is only 50/100, indicating moderate reliability
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Current Price
$46.73
Analyst Target
$48.64
Upside/Downside
+4.1%
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for SLB and closest competitors.
Updated 2026-01-16
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
SLB
SLB N.V.
Primary
|
+104.7% | -13.8% | +17.3% | +42.5% | +21.3% | +3.4% |
|
KMI
Kinder Morgan, Inc.
Peer
|
+168.4% | +73.3% | +7.0% | -0.2% | +0.4% | +3.3% |
|
EOG
EOG Resources, Inc.
Peer
|
+120.3% | -10.1% | -21.1% | -9.6% | +0.6% | +0.4% |
|
VLO
Valero Energy Corporation
Peer
|
+263.6% | +46.2% | +35.8% | +27.4% | +12.6% | -1.0% |
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Historical data shows last 12 quarters (3 years)
Valuation Metrics
Key valuation ratios and pricing indicators
P/E Ratio
18.18
Forward P/E
15.85
PEG Ratio
N/A
P/B Ratio
2.72
P/S Ratio
1.98
EV/Revenue
2.28
EV/EBITDA
10.45
Market Cap
$69.81B
Profitability
Profit margins and return metrics
Profit Margin
10.34%
Operating Margin
15.48%
Gross Margin
19.31%
ROE
15.18%
ROA
6.86%
Growth
Revenue and earnings growth rates
Revenue Growth
-2.5%
Earnings Growth
-39.8%
Q/Q Revenue Growth
N/A
Q/Q Earnings Growth
-37.7%
Financial Health
Balance sheet strength and liquidity metrics
Debt/Equity
0.47
Low debt
Current Ratio
1.39
Good
Quick Ratio
0.9
Poor
Cash/Share
$2.4
Quarterly Earnings History
EPS performance vs analyst estimates
2026-01-23
$N/A
2025-10-17
$0.5
-24.7% surprise
2025-07-18
$0.74
+1.9% surprise
2025-04-25
$0.58
-21.4% surprise
Energy Sector Comparison
Comparing SLB against 26 companies in the Energy sector
(0 bullish, 20 neutral, 6 bearish)
P/E Ratio
18.18
This Stock
vs
23.13
Sector Avg
-21.4%
(Discount)
Return on Equity (ROE)
15.18%
This Stock
vs
7.95%
Sector Avg
+90.9%
(Excellent)
Profit Margin
10.34%
This Stock
vs
8.82%
Sector Avg
+17.2%
(Superior)
Debt to Equity
0.47
This Stock
vs
0.68
Sector Avg
-29.8%
(Less Debt)
Revenue Growth
-2.5%
This Stock
vs
4.1%
Sector Avg
-161.0%
(Slower)
Current Ratio
1.39
This Stock
vs
1.18
Sector Avg
+17.1%
(Stronger)
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
SLB
SLB N.V.
|
NEUTRAL | $69.81B | 18.18 | 15.2% | 10.3% | $46.73 | |
|
KMI
Kinder Morgan, Inc.
|
NEUTRAL | $61.0B | 22.48 | 8.9% | 16.6% | $27.42 | |
|
BKR
Baker Hughes Company
|
NEUTRAL | $58.23B | 22.66 | 14.6% | 9.3% | $58.92 | |
|
EOG
EOG Resources, Inc.
|
NEUTRAL | $57.5B | 10.46 | 18.5% | 24.4% | $105.32 | |
|
VLO
Valero Energy Corporation
|
NEUTRAL | $56.99B | 38.06 | 5.2% | 1.3% | $183.46 |
Recent Insider Trading
Insider buy and sell transactions from the last 6 months
| Date | Insider | Position | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2025-11-26 | COLEMAN PETER JOHN | Director | Sale | 5,500 | $197,010 |
| 2025-11-13 | BIGUET STEPHANE | Chief Financial Officer | Sale | 38,447 | $1,412,927 |
| 2025-11-11 | MERAD ABDELLAH | Officer | Sale | 60,000 | $2,261,400 |
| 2025-09-12 | RALSTON DIANNE B | Officer | Sale | 39,727 | $1,433,350 |
Insider transactions can signal confidence or concerns about company prospects
Wall Street Analysts
Professional analyst ratings and price targets
Consensus
STRONG_BUY
29 analysts
Susquehanna
2026-01-07
Positive
Positive
Evercore ISI Group
2026-01-06
In-Line
Outperform
Freedom Capital Markets
2026-01-06
Buy
Hold
Piper Sandler
2025-12-18
Overweight
Overweight
Barclays
2025-12-17
Overweight
Overweight
UBS
2025-12-12
Buy
Buy
Citigroup
2025-12-11
Buy
Buy
TD Cowen
2025-12-11
Buy
Buy
Bernstein
2025-12-11
Outperform
Outperform
Rothschild & Co
2025-11-03
Buy
Past News Coverage
Recent headlines mentioning SLB from our newsroom.
Newest → oldest
No matching news yet.